LKC Technologies, Inc.: Clinical Trials

3 trials sponsored by LKC Technologies, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3

Follow LKC Technologies, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RETeval All Comers Trial (REACT)
RETeval - Retinal Disease, Electroretinogram
Not applicableCompletedLKC Technologies, Inc.6642017-02-132025-12-17
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
RETeval color flicker ERG, RETeval dilated versus un-dilated flicker ERG, pupil dilation - Retinopathy
Not applicableCompletedLKC Technologies, Inc.182015-03-012025-12-17
RETeval Study for Diabetic Retinopathy
RETeval - Diabetic Retinopathy
Not applicableCompletedInoveon Corporation4682013-09-012017-06-12

Conditions studied

Retinal Diseases (2)  ·  Diabetic Retinopathy (1)

Countries

United States (3)

Top investigators

Olga Kraszewska, Ph.D. (1)  ·  Stephen R Fransen, MD (1)

Results publications

PMID 28160194

NIH funding

R44EY021121 (1)